Mallinckrodt to launch mid-stage study of Acthar Gel in ALS in H1 2017
Mallinckrodt to launch mid-stage study of Acthar Gel in ALS in H1 2017
Mallinckrodt to launch mid-stage study of Acthar Gel in ALS in H1 2 17 - Mallinckrodt PLC (NYSE:MNK) | Seeking Alpha |
All times are GMT -5. The time now is 12:12 AM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.